Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 20 de 29
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
1.
Am J Vet Res ; 62(11): 1721-6, 2001 Nov.
Artigo em Inglês | MEDLINE | ID: mdl-11703014

RESUMO

OBJECTIVE: To test the ability of a single injection of a sustained-release formulation of moxidectin (moxidectin SR) to protect dogs against heartworm infection for 180 days after inoculation with infective third-stage larvae (L3) of Dirofilaria immitis. ANIMALS: 32 adult mixed-breed dogs. PROCEDURE: Dogs were allocated to 4 groups on the basis of weight and sex. Dogs were injected SC with saline (0.9% NaCl) solution or moxidectin SR at the rate of 0.06, 0.17, or 0.5 mg/kg of body weight (day 0). Each dog was inoculated SC with 50 D immitis L3 180 days later. On days 330 and 331, dogs were euthanatized. The heart, lungs, and thoracic cavity were examined, and number and sex of heartworms were determined. RESULTS: A mean of 35.9 heartworms was recovered from untreated control dogs. Fourteen worms were recovered from 1 of 8 dogs given moxidectin SR at the lowest dosage, and none of the dogs in the 2 highest moxidectin treatment groups were infected. Small barely palpable granulomas were detected at injection sites of moxidectin-treated dogs. Frequency and size of granulomas were positively correlated with dose of moxidectin administered. CONCLUSIONS AND CLINICAL RELEVANCE: A single dose of moxidectin SR at a dosage as low as 0.17 mg/kg can safely and reliably confer complete protection against infection after challenge-exposure with D. immitis L3, and protection lasts for at least 180 days. This mode of prophylactic treatment against infection with heartworms effectively eliminates failure of prophylaxis that results from erratic administration of medications designed for monthly administration.


Assuntos
Antibacterianos/administração & dosagem , Dirofilaria immitis , Dirofilariose/prevenção & controle , Doenças do Cão/prevenção & controle , Animais , Antibacterianos/sangue , Antibacterianos/farmacocinética , Preparações de Ação Retardada , Dirofilariose/parasitologia , Cães , Feminino , Granuloma/patologia , Granuloma/veterinária , Coração/parasitologia , Histocitoquímica/veterinária , Injeções Subcutâneas/veterinária , Pulmão/parasitologia , Macrolídeos , Masculino , Microesferas , Distribuição Aleatória , Pele/patologia
2.
J Parasitol ; 87(2): 322-9, 2001 Apr.
Artigo em Inglês | MEDLINE | ID: mdl-11318562

RESUMO

Heads of 109,597 mosquitoes collected during 1996 and 1997 from Gainesville, Florida (1996, n = 39,131; 1997, = 34,209), Bartow, Florida (1996, n = 12,000; 1997, n = 12,000), and Baton Rouge, Louisiana (1996, n = 12,257) were tested by a polymerase chain reaction and Southern hybridization-based test for the presence of third-stage larvae of the canine heartworm Dirofilaria immitis. Mosquito heads were pooled (1-200 heads) by month, locality, and species for testing. The test used was species specific for D. immitis and was capable of detecting DNA from a single larva in a pool of 200 mosquito heads. Specificity for the third larval stage was achieved by probing only mosquito heads. One or more D. immitis-infected mosquito heads were detected in each month of the year from Barrow in both 1996 and 1997. No infected mosquito heads were detected from Gainesville or Baton Rouge in December, January, February, or March. These results are in general agreement with previous sentinel dog and model prediction studies that showed heartworm transmission in the warm temperate Gulf coast region of the United States to be seasonal rather than continuous as previously believed.


Assuntos
Culicidae/parasitologia , Dirofilaria immitis/isolamento & purificação , Insetos Vetores/parasitologia , Animais , Southern Blotting , Dirofilariose/epidemiologia , Dirofilariose/transmissão , Doenças do Cão/epidemiologia , Doenças do Cão/transmissão , Cães , Ecossistema , Florida/epidemiologia , Larva , Louisiana/epidemiologia , Reação em Cadeia da Polimerase , Prevalência , Estações do Ano , Vigilância de Evento Sentinela/veterinária
4.
Clin Tech Small Anim Pract ; 13(2): 77-82, 1998 May.
Artigo em Inglês | MEDLINE | ID: mdl-9753795

RESUMO

The current emphasis on heartworm prevention reflects the dependable protection provided by the monthly administered macrolide endectocides. This article reviews the prerequisites for heartworm transmission and the importance of daily temperature as a limiting factor in determining the seasonality of the transmission period. The practice of some veterinarians to continuously prescribe monthly chemoprophylaxis exaggerates the actual risk of heartworm transmission in most parts of the country and unnecessarily increases the cost of protection to their clients. Guidelines are provided for making an objective, conservative estimate of the earliest and latest dates for administering monthly chemoprophylaxis; and the use of seasonal projections for other clinical applications such as timing and interpretation of heartworm testing are discussed.


Assuntos
Antinematódeos/uso terapêutico , Dirofilariose/transmissão , Doenças do Cão/transmissão , Animais , Antinematódeos/administração & dosagem , Dirofilariose/tratamento farmacológico , Transmissão de Doença Infecciosa/veterinária , Doenças do Cão/tratamento farmacológico , Cães , Esquema de Medicação , Guias como Assunto , Fatores de Risco , Estações do Ano
5.
Trop Med Parasitol ; 46(4): 235-40, 1995 Dec.
Artigo em Inglês | MEDLINE | ID: mdl-8826103

RESUMO

Normal adult Dirofilaria immitis from a microfilaremic donor dog and D. immitis from donors rendered microfilaria (MF) negative by seven consecutive monthly doses of milbemycin oxime (500 micrograms/kg) were transplanted into three previously uninfected and untreated dogs. Two dogs received reciprocal combinations of treated and untreated D. immitis and the third received untreated adults of both sexes. A fourth dog served as an infected, milbemycin treated, non-transplanted control. Eleven weeks after pairing treated female with untreated male worms, a low-level microfilaremia developed in the recipient. Two of the three treated female worms recovered from this dog were non-fertile, and the third contained a small number of elongate and coiled embryos but no mature intrauterine (stretched) microfilariae (MFF). The dog receiving treated male and untreated female worms became microfilaremic after two weeks. Microfilaremia peaked at 37,000/ml 16 weeks after transplantation and declined over the next 20 weeks to 7,200/ml. Untreated females paired with treated males either became non-fertile or exhibited low numbers of developing embryos and MFF scattered throughout their reproductive tracts. Pairing of untreated male and female worms produced a mcirofilaremia during the second post-operative week, which plateaued around 15,000 MFF per ml. Females recovered after this pairing contained a normal pattern of embryonic development, including stretched MFF. There were no significant differences in the percentage composition or absolute numbers of developing and mature sperm in the reproductive tracts of treated and untreated male worms. However, the resumption of MF production in one milbemycin treated female worm after pairing with normal males and failure of treated males to sustain MF production in untreated female worms suggest that milbemycin oxime impairs the sexual competence of male D. immitis. This may explain the ability of this drug to bring about long term suppression of microfilaremia without immediate adulticidal activity.


Assuntos
Antibacterianos/farmacologia , Dirofilaria immitis/efeitos dos fármacos , Macrolídeos , Animais , Dirofilaria immitis/fisiologia , Cães , Feminino , Masculino , Reprodução , Espermatogênese/efeitos dos fármacos
6.
Lab Anim Sci ; 44(5): 453-61, 1994 Oct.
Artigo em Inglês | MEDLINE | ID: mdl-7844953

RESUMO

The interactions of the systemic and myocardial adaptations during and after rapid ventricular pacing, a model of heart failure, were assessed in conscious, unstressed dogs. Ultrasonic probes and vascular catheters were surgically implanted into dogs for measurements of blood flows and pressures during 3 weeks of pacing and after 2 months of recovery. Three weeks of tachycardia (260 beats/min) resulted in a marked reduction in hemodynamic parameters and left ventricular dilatation, with caudal wall thinning throughout the pacing period and 1 week of recovery. Sinus rhythm resumed after the pacer was turned off, with return toward normal in hemodynamic parameters; however, left ventricular dilatation and ventricular remodeling, with significant fibrosis, loss of myocytes, and hypertrophy of the surviving cells were still present after 2 months of recovery. In conclusion, even though hemodynamic parameters normalized during recovery, adaptive myocardial remodeling caused permanent ventricular fibrosis, hypertrophy, and increased cardiac filling pressures.


Assuntos
Estimulação Cardíaca Artificial , Modelos Animais de Doenças , Insuficiência Cardíaca/fisiopatologia , Coração/fisiopatologia , Animais , Cateterismo , Cães/cirurgia , Feminino , Insuficiência Cardíaca/diagnóstico por imagem , Insuficiência Cardíaca/patologia , Ventrículos do Coração/diagnóstico por imagem , Ventrículos do Coração/patologia , Ventrículos do Coração/fisiopatologia , Hemodinâmica , Masculino , Contração Miocárdica , Tamanho do Órgão , Taquicardia , Ultrassonografia
7.
Vet Clin North Am Small Anim Pract ; 21(5): 879-904, 1991 Sep.
Artigo em Inglês | MEDLINE | ID: mdl-1949498

RESUMO

The clinical literature on the subject of inotropic therapy of heart failure, particularly use of digitalis glycosides, is full of contradictions. Most of this disparity can be accounted for if not reconciled by taking the methodology of the clinical trials into consideration. Because drug interventions may produce subtle effects requiring a subjective determination, the questions being asked in these studies cannot be answered without removing as many sources of bias as possible from the patient management and data analysis. If a study has not been adequately randomized, double-blinded, and placebo-controlled, the clinical findings will be inconclusive at best. Systolic myocardial dysfunction plays a pivotal role in the pathogenesis of CHF in many patients and is a prerequisite for the use of cardiotonic drugs. Although the clinical signs of heart failure may be relieved initially by diuretics and vasodilators, compensation may require the addition of a positive inotrope, particularly in advanced cases. In veterinary medicine, the choice of positive inotrope is limited to digoxin, digitoxin, dobutamine, or amrinone. Digoxin possesses superior pharmacokinetics and is the cardiac glycoside of choice for use in the dog. Dobutamine and amrinone are more potent inotropes, but since they must be administered by continuous intravenous infusion, their use is limited to critical care therapy. At the present time, only digoxin can be administered orally for sustained long-term maintenance therapy. Milrinone, a more potent derivative of amrinone, also offers this option, but it has not been available since its brief trial debut as an investigational drug. None of the nonglycoside alternatives couples the benefits of positive inotropic and negative chronotropic effects. Consequently, digoxin remains the mainstay for chronic inotropic support of the heart. Atrial fibrillation with a rapid ventricular response rate is the prime indication for digoxin. In the last few years, evidence from methodologically sound clinical trials on humans has also restored faith in the efficacy of digoxin for treating heart failure in patients with normal sinus rhythm. From these studies, the profile of a digitalis responsive heart failure patient has emerged. Digoxin is most likely to be efficacious when heart failure is associated with chronic, severe ventricular systolic dysfunction, which has resulted in ventricular dilatation. The most reliable clinical marker is the presence of a third heart sound (gallop rhythm). Although the patients in the worst heart failure generally have the shortest survival time, they may also have the most dramatic short-term clinical benefit. However, once cardiac reserve is exhausted in the terminal stages of failure, cardiotonic stimulation ceases to be effective.(ABSTRACT TRUNCATED AT 400 WORDS)


Assuntos
Cardiotônicos/uso terapêutico , Doenças do Cão/tratamento farmacológico , Insuficiência Cardíaca/veterinária , Animais , Catecolaminas/uso terapêutico , Digitoxina/uso terapêutico , Digoxina/uso terapêutico , Cães , Insuficiência Cardíaca/tratamento farmacológico , Humanos , Inibidores de Fosfodiesterase/uso terapêutico
8.
J Vet Intern Med ; 5(4): 232-8, 1991.
Artigo em Inglês | MEDLINE | ID: mdl-1941757

RESUMO

M-mode echocardiography was completed and plasma taurine concentrations were determined in 79 healthy cats and 77 cats with dilated cardiomyopathy (DCM). In healthy cats, a relationship was not observed between plasma taurine concentrations and any M-mode echocardiographic measurement. End-systolic and end-diastolic cardiac chamber dimensions were larger; wall thickness measures were smaller; and calculations of fractional shortening were less in cats with DCM than in healthy cats. Plasma taurine concentrations less than 30 nmol/mL were detected in 7/79 healthy cats and in 52/77 cats with DCM. Of the 52 cats with DCM and an initial plasma taurine concentration less than 30 nmol/mL, 23 died or were euthanized during the first post-treatment week, 7 were lost to further study, and 22 improved after taurine supplementation. Of the 25 cats with DCM and an initial plasma taurine concentration greater than or equal to 30 nmol/mL, 9 died or were euthanatized during the first post-treatment week, and 9 were lost to further study. Two cats did not improve, of which one died and one was euthanatized 4 to 8 weeks after initiation of taurine supplementation. Five cats with a plasma taurine concentration greater than or equal to 30 nmol/mL improved after taurine supplementation. Myocardial function subsequently deteriorated in three of these cats. Two of the three cats had signs of congestive heart failure redevelop.


Assuntos
Cardiomiopatia Dilatada/veterinária , Doenças do Gato/sangue , Ecocardiografia/veterinária , Taurina/sangue , Animais , Peso Corporal , Cardiomiopatia Dilatada/sangue , Cardiomiopatia Dilatada/diagnóstico por imagem , Doenças do Gato/diagnóstico por imagem , Gatos , Feminino , Masculino , Análise de Regressão
9.
Am J Vet Res ; 52(4): 543-50, 1991 Apr.
Artigo em Inglês | MEDLINE | ID: mdl-2053722

RESUMO

Transcutaneous pulsed-wave Doppler echocardiography was used to obtain velocity signals from the aortic and pulmonary roots of clinically normal adult dogs tranquilized with acepromazine. Doppler-derived variables included peak ejection velocity, ejection time, and velocity-time integral. The cross-sectional areas of the left and right ventricular outflow tracts were estimated from diameters of the respective orifices measured from two-dimensional echocardiographic images. These data were used to calculate stroke volume and cardiac output for each ventricle. Linear, single variable regressions of ejection time, velocity-time integral, and peak velocity with body weight showed no significant correlations. Significant correlations existed between body weight and estimated left and right ventricular stroke volume and cardiac output. A close correspondence existed between pulmonary and aortic determinations of velocity-time integral, stroke volume, and cardiac output. These results provide an initial framework for interpretation of clinical data by veterinary cardiologists.


Assuntos
Valva Aórtica/fisiologia , Cães/fisiologia , Ecocardiografia Doppler/veterinária , Valva Pulmonar/fisiologia , Animais , Valva Aórtica/diagnóstico por imagem , Insuficiência da Valva Aórtica/diagnóstico por imagem , Insuficiência da Valva Aórtica/veterinária , Velocidade do Fluxo Sanguíneo/veterinária , Débito Cardíaco , Doenças do Cão/diagnóstico por imagem , Feminino , Ventrículos do Coração/diagnóstico por imagem , Masculino , Valva Pulmonar/diagnóstico por imagem , Insuficiência da Valva Pulmonar/diagnóstico por imagem , Insuficiência da Valva Pulmonar/veterinária , Valores de Referência , Volume Sistólico , Função Ventricular
10.
J Helminthol ; 62(3): 175-80, 1988 Sep.
Artigo em Inglês | MEDLINE | ID: mdl-3192909

RESUMO

The percentage composition and spatial distribution of embryogenic stages in the uteri of female Dirofilaria immitis were examined at various times after treatment with a microfilaricidal dose of ivermectin and compared to nontreated parasites. Worms sampled 42 days post-treatment (PT) exhibited an increased proportion of stretched microfilariae in the distal portion of the uterus. A decreased proportion of developed embryos was noted in the mid body region of worms sampled 42 days PT, and these forms were completely absent from the proximal area of the uterus. Relative numbers and spatial distribution of other stages remained virtually identical to controls. Radical changes in the composition and spatial distribution of embryogenic forms were noted in the uteri of a single worm sampled 80 days PT. Unlike nontreated parasites and worms sampled 42 days PT, stretched microfilariae constituted the predominant form in the distal uterus of this worm, and these stages were found in decreasing numbers throughout the proximal segments. Also, the intermediate embryogenic stages were either rare or absent.


Assuntos
Dirofilaria immitis/efeitos dos fármacos , Filarioidea/efeitos dos fármacos , Ivermectina/farmacologia , Animais , Dirofilaria immitis/embriologia , Desenvolvimento Embrionário e Fetal/efeitos dos fármacos , Feminino , Microfilárias/efeitos dos fármacos
11.
Vet Clin North Am Small Anim Pract ; 17(6): 1463-518, 1987 Nov.
Artigo em Inglês | MEDLINE | ID: mdl-3328398

RESUMO

Dirofilaria immitis is an epizootic filarial parasite that most often infects domestic dogs. This article provides information about the life cycle of Dirofilaria immitis as well as the epidemiology, diagnosis, clinical signs, and treatment of heartworm infection.


Assuntos
Dirofilariose/veterinária , Doenças do Cão/parasitologia , Animais , Cães
12.
J Vet Intern Med ; 1(4): 163-9, 1987.
Artigo em Inglês | MEDLINE | ID: mdl-3506101

RESUMO

In a dog, tricuspid regurgitation due to congenital tricuspid dysplasia resulted in extreme right heart enlargement and right heart failure. Incessant supraventricular tachycardias were present, requiring the intravenous administration of verapamil to reduce the ventricular rate. Oral therapy using a combination of verapamil and quinidine was partially effective in controlling the ventricular rate during the following week. At that time, electrophysiologic studies were performed. They revealed that a succession of several atrial tachycardias with different cycle lengths, including one episode of atrial flutter, was present. Atrial activity was spanning the majority of the cycle length in all these arrhythmias. Epicardial mapping was performed during the atrial flutter. This enabled the detection of a depolarization wave-front traveling counterclockwise from the dorsolateral right atrium toward the right appendage, following the tricuspid valve annulus. No areas of abnormal conduction were detected. Because programmed electric stimulation maneuvers could not be performed, definitive conclusions about the mechanism of the arrhythmia could not be drawn. The two most likely possibilities were circus movement using part of the dilated tricuspid valve annulus as an anatomic barrier or a leading circle type of re-entry.


Assuntos
Doenças do Cão/fisiopatologia , Taquicardia/veterinária , Valva Tricúspide/anormalidades , Animais , Doenças do Cão/tratamento farmacológico , Doenças do Cão/patologia , Cães , Eletrocardiografia , Masculino , Quinidina/uso terapêutico , Taquicardia/tratamento farmacológico , Taquicardia/patologia , Taquicardia/fisiopatologia , Valva Tricúspide/patologia , Insuficiência da Valva Tricúspide/congênito , Insuficiência da Valva Tricúspide/veterinária , Verapamil/uso terapêutico
14.
Am J Vet Res ; 46(8): 1705-11, 1985 Aug.
Artigo em Inglês | MEDLINE | ID: mdl-4037497

RESUMO

Body weight, heart rate, and 19 M-mode echocardiographic variables were measured in 41 nonanesthetized healthy cats. Estimated limits were determined for the echocardiographic variables, and each variable was then correlated to body weight, heart rate, and the 18 other variables. A significant (P less than 0.05) positive correlation to body weight was found with aortic diameter, left atrial dimension, septal and left ventricular systolic and left ventricular diastolic wall thicknesses, and left and right ventricular diastolic and right ventricular systolic internal dimensions. Significant inverse correlation (P less than 0.05) to heart rate was found with body weight, left ventricular systolic and diastolic and right ventricular systolic internal dimensions, left atrial dimension, left atrial dimension to aortic ratio, mitral valve E point to ventricular septal separation, and left ventricular ejection time. Left ventricular shortening fraction in the short axis and velocity of circumferential fiber shortening were significantly correlated (P less than 0.05) to heart rate. Significant correlation (P less than 0.05) was also found between many echocardiographic variables.


Assuntos
Peso Corporal , Gatos/anatomia & histologia , Ecocardiografia/veterinária , Frequência Cardíaca , Coração/anatomia & histologia , Animais , Gatos/genética , Gatos/fisiologia , Feminino , Masculino
15.
Am J Vet Res ; 46(8): 1712-3, 1985 Aug.
Artigo em Inglês | MEDLINE | ID: mdl-4037498

RESUMO

Determination was made of changes in heart rate and certain M-mode echocardiographic values in healthy cats given ketamine (3 to 5 mg/kg, IM). Heart rate and septal and left ventricular posterior wall thickness in diastole increased, and left ventricular internal diameter in diastole and shortening fraction decreased (P less than 0.02) after ketamine was given. With the adjustment for heart rate by analysis of covariance, left ventricular internal diameter in diastole, shortening fraction, and velocity of circumferential fiber shortening were significantly decreased (P less than 0.05) from base-line values.


Assuntos
Gatos/anatomia & histologia , Ecocardiografia/veterinária , Coração/efeitos dos fármacos , Ketamina/farmacologia , Animais , Gatos/genética , Gatos/fisiologia , Feminino , Coração/anatomia & histologia , Frequência Cardíaca/efeitos dos fármacos , Masculino
16.
J Parasitol ; 71(1): 56-61, 1985 Feb.
Artigo em Inglês | MEDLINE | ID: mdl-3981349

RESUMO

Antibody to Dirofilaria immitis was measured in 6 dogs before and after treatment with thiacetarsamide. Antibody to microfilarial surface antigens was ascertained with an indirect fluorescent antibody assay (IFA). Various patterns of the production, or presence, of antibody to microfilarial surface antigens were observed. There was no apparent relationship between IFA results and adulticide success. Antibody to adult worm antigen was measured with an enzyme-linked immunosorbent assay (ELISA). ELISA titers increased following infection and decreased transiently at the end of the prepatent period. A marked increase in ELISA titers was noted in all dogs subsequent to an initial thiacetarsamide treatment. In general, ELISA titers returned to low levels in dogs which were successfully treated; however, in dogs with persistent infections or infections which apparently necessitated 2 adulticide treatments ELISA titers remained at pre-treatment levels during the period of observation. Since ELISA titers appeared to decrease to pre-infection levels in successfully treated dogs, the assay should have utility in subsequent antibody determinations and may permit retrospective prediction of chemotherapeutic success.


Assuntos
Dirofilaria immitis/imunologia , Dirofilariose/imunologia , Filarioidea/imunologia , Animais , Anti-Helmínticos/administração & dosagem , Anti-Helmínticos/imunologia , Anticorpos/análise , Formação de Anticorpos , Antígenos de Helmintos/imunologia , Antígenos de Superfície/imunologia , Dirofilariose/tratamento farmacológico , Cães
18.
J Am Vet Med Assoc ; 172(1): 61-2, 1978 Jan 01.
Artigo em Inglês | MEDLINE | ID: mdl-624662

RESUMO

A rapid rise in rectal temperature (to 45 C) in a young male Greyhound was attributed to the use of halothane and succinylcholine. Circulatory failure and death occurred within approximately 90 minutes of the onset of the hyperthermia.


Assuntos
Doenças do Cão , Hipertermia Maligna/veterinária , Anestesia por Inalação/veterinária , Animais , Doenças do Cão/etiologia , Doenças do Cão/fisiopatologia , Cães , Halotano/efeitos adversos , Masculino , Hipertermia Maligna/etiologia , Hipertermia Maligna/fisiopatologia , Succinilcolina/efeitos adversos
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...